Shanghai Pharmaceuticals Holding Co., Ltd (SHSE: 601607)
Health Care · Health Care Providers & Services · CN
CN¥16.19
-2.41% today · -16.9% 1Y
Shanghai Pharmaceuticals Holding Co., Ltd (SHSE: 601607) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $8.09B and employs 49,608 people.
Over the last twelve months the share price has lost 16.9%, trading between 15.01 and 19.50.
Tweenvest scores Shanghai Pharmaceuticals Holding Co., Ltd across four factors: quality 77/100, value 73/100, growth 56/100, dividend 65/100. Its strongest factor is quality.
601607 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $8.09B
- Revenue (TTM)
- $41.77B
- P/E
- 10.36
- EPS
- 1.56
- Dividend yield
- 2.90%
- Beta (5Y)
- 0.16
- 52-week high
- CN¥19.50
- 52-week low
- CN¥15.01
- Avg volume (3M)
- —
- Shares outstanding
- 3.71B
- Employees
- 49,608
- Next earnings
- —
About Shanghai Pharmaceuticals Holding Co., Ltd
Shanghai Pharmaceuticals Holding Co., Ltd., a diversified investment holding entity established in 1994 and headquartered in Shanghai, China, plays a crucial role in the People's Republic of China's pharmaceutical and healthcare sectors. As a subsidiary of Shanghai Pharmaceutical (Group) Co., Ltd., its extensive operations encompass research, development, manufacturing, distribution, and retail of a wide array of products. The company's business model is structured around four principal segments: Production, Distribution, Retail, and an 'Others' category. Within its Production segment, it develops and manufactures a broad portfolio of pharmaceuticals, including chemical and biochemical drugs, traditional Chinese medicines, healthcare solutions, and medical devices. These offerings target diverse therapeutic fields such as oncology, cardiovascular and cerebrovascular conditions, central nervous system disorders, general infections, immunological diseases, digestive and metabolic ailments, and respiratory issues. The company's product range comprises approximately 700 distinct drug varieties. Beyond manufacturing, its Distribution arm is instrumental in providing comprehensive pharmaceutical supply chain solutions. This includes warehousing, logistics, and value-added services for various industry players, from pharmaceutical manufacturers to dispensers like hospitals, other distributors, and retail pharmacies. Furthermore, the company manages an extensive network of retail pharmacies, alongside a burgeoning online drug sales platform. This retail footprint spans approximately 2,000 chain pharmacies across 24 provinces. Its 'Others' segment encompasses a variety of support and innovative services, such as consulting, asset management, clinical trial coordination, medical assistance programs, educational initiatives for healthcare professionals and patients, e-prescription management systems, and the development of remote and cloud hospital technologies.
- ISIN
- CNE000000C82
- Founded
- 1994
- Listed since
- Mar 24, 1994
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| UnitedHealth Group IncorporatedNYSE: UNH | $350.16B | $397.59 | +1.92% |
| CVS Health CorporationNYSE: CVS | $118.97B | $93.06 | +0.04% |
| McKesson CorporationNYSE: MCK | $100.14B | $867.80 | +1.04% |
| HCA Healthcare, Inc.NYSE: HCA | $92.92B | $431.21 | +0.47% |
| Elevance Health, Inc.NYSE: ELV | $86.86B | $402.43 | +0.47% |
| The Cigna GroupNYSE: CI | $73.33B | $278.09 | +0.21% |
| Cencora, Inc.NYSE: COR | $60.69B | $323.29 | +1.65% |
| Cardinal Health, Inc.NYSE: CAH | $53.38B | $230.01 | +0.22% |
Figures last refreshed Aug 18, 2026.